HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) Cyclically Adjusted Book per Share: ¥6.98 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603567 HeiLongJiang ZBD Pharmaceutical Co Ltd SHSE:603567
33 GF Score
Price ¥6.88
GF Value ¥1.93
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is HeiLongJiang ZBD Pharmaceutical Co Cyclically Adjusted Book per Share?

HeiLongJiang ZBD Pharmaceutical Co SHSE:603567 +6.83% 33 Cyclically Adjusted Book per Share is ¥6.98 as of Mar. 2026. GuruFocus rates SHSE:603567 with a GF Score™ of 33/100 and a GF Value™ of ¥1.93 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

HeiLongJiang ZBD Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥6.485. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥6.98 for the trailing ten years ended in Mar. 2026.

During the past 12 months, HeiLongJiang ZBD Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-28), HeiLongJiang ZBD Pharmaceutical Co's current stock price is ¥6.88. HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥6.98. HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 0.99.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HeiLongJiang ZBD Pharmaceutical Co was 3.07. The lowest was 0.61. And the median was 1.75.


HeiLongJiang ZBD Pharmaceutical Co  (SHSE:603567) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.88/6.98
=0.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HeiLongJiang ZBD Pharmaceutical Co was 3.07. The lowest was 0.61. And the median was 1.75.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


HeiLongJiang ZBD Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


HeiLongJiang ZBD Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeiLongJiang ZBD Pharmaceutical Co Cyclically Adjusted Book per Share Chart

HeiLongJiang ZBD Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 6.18 6.55 6.93

HeiLongJiang ZBD Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.71 6.78 6.88 6.93 6.98

SHSE:603567 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeiLongJiang ZBD Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:603567
33GF Score
HeiLongJiang ZBD Pharmaceutical Co Ltd SHSE:603567
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeiLongJiang ZBD Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HeiLongJiang ZBD Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.485/116.3033*116.3033
=6.485

Current CPI (Mar. 2026) = 116.3033.

HeiLongJiang ZBD Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 4.710 101.400 5.402
201609 4.912 102.400 5.579
201612 5.065 102.600 5.741
201703 5.204 103.200 5.865
201706 5.120 103.100 5.776
201709 5.303 104.100 5.925
201712 5.499 104.500 6.120
201803 5.684 105.300 6.278
201806 5.605 104.900 6.214
201809 5.751 106.600 6.274
201812 5.856 106.500 6.395
201903 6.055 107.700 6.539
201906 5.971 107.700 6.448
201909 6.090 109.800 6.451
201912 6.173 111.200 6.456
202003 6.323 112.300 6.548
202006 6.174 110.400 6.504
202009 6.240 111.700 6.497
202012 6.470 111.500 6.749
202103 6.654 112.662 6.869
202106 6.796 111.769 7.072
202109 6.090 112.215 6.312
202112 7.477 113.108 7.688
202203 7.645 114.335 7.777
202206 7.625 114.558 7.741
202209 7.513 115.339 7.576
202212 7.536 115.116 7.614
202303 7.787 115.116 7.867
202306 7.635 114.558 7.751
202309 7.739 115.339 7.804
202312 8.013 114.781 8.119
202403 8.326 115.227 8.404
202406 8.432 114.781 8.544
202409 8.244 115.785 8.281
202412 8.288 114.893 8.390
202503 8.370 115.116 8.456
202506 8.206 114.907 8.306
202509 7.745 115.471 7.801
202512 6.675 115.832 6.702
202603 6.485 116.303 6.485

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥6.98 mean?
HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) has a Cyclically Adjusted Book per Share of ¥6.98 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on HeiLongJiang ZBD Pharmaceutical Co and its competitors.
Is HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
HeiLongJiang ZBD Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥6.98. Overall, HeiLongJiang ZBD Pharmaceutical Co has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
HeiLongJiang ZBD Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥6.98 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on HeiLongJiang ZBD Pharmaceutical Co and its competitors. HeiLongJiang ZBD Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥6.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeiLongJiang ZBD Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.93, compared to a current price of ¥6.88 — trading 256.5% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥6.98. HeiLongJiang ZBD Pharmaceutical Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567), the current Cyclically Adjusted Book per Share is ¥6.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) Overvalued in 2026?

Based on GuruFocus' analysis, HeiLongJiang ZBD Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥6.88 is trading 256.5% above its estimated GF Value™ of ¥1.93. GuruFocus considers HeiLongJiang ZBD Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603567:

  • Cyclically Adjusted Book per Share: ¥6.98
  • GF Value™: ¥1.93 vs. price of ¥6.88 (256.5% above fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603567 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HeiLongJiang ZBD Pharmaceutical Co Business Description

Address No. 72, Hongxing Street, Hulin Town, Heilongjiang Province, Hulin, CHN, 158400
HeiLongJiang ZBD Pharmaceutical Co Ltd operates as a pharmaceutical manufacturer. The business scope of the company includes wholesale, retail, traditional Chinese medicine decoction pieces, Chinese medicine formula granules, Chinese herbal medicine trade, medical equipment, sanitary materials, and inspection and testing.
33GF Score

Get the complete analysis for SHSE:603567

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.88
Price
¥1.93
GF Value